[Elsevier] MUC1: An emerging target in cancer treatment and diagnosis |
|
This post will be closed automatically in 2026-10-30 13:16
Reward10points
|
post
reply
points
50
10
Recent development of chemiluminescence for bioanalysis
10
Development of a Python-based tool for evaluation of multivariate decision risk considering measurement uncertainty and correlation effects
10
A fast, non-invasive auxiliary screening algorithm for lung cancer based on electronic nose system
10
The chemiluminescence paper-based analytical device for lead measurement in gasoline
20
Safety, tolerability, and efficacy of alixorexton, a selective orexin 2 receptor agonist for narcolepsy type 1 (Vibrance-1): a randomised, double-blind, placebo-controlled, phase 2 trial
